This article is more than 5 years old. Information may no longer be current.
Take Steps fundraiser supports research on individualized IBD treatment
Click Here to Manage Email Alerts
For patients with Crohn’s disease and ulcerative colitis, the goal of individualized treatment plans based on genetic and microbial targets is coming closer to fruition through fundraising programs by the Crohn’s and Colitis Foundation of America, the foundation said in a press release.
One of the key fundraising initiatives underway, Take Steps, is a national walk designed to raise funds for research and public awareness of Crohn’s disease and ulcerative colitis. Funds raised through such programs will be used to advance research into individualized treatments, and the research will be conducted through the foundation’s Genetics and Microbiome Research initiatives.
According to Caren Heller, MD, chief scientific officer of the Crohn’s and Colitis Foundation of America (CCFA), this research holds great promise for developing new treatment approaches to inflammatory bowel disease.
“We anticipate that in the next 3 to 5 years, we will identify novel genetic and antimicrobial targets that will form the basis for new therapeutic interventions,” she said in a press release.
The Take Steps walk is currently in its 7th year, and has been the impetus for more than 45 walks throughout the country. The family-friendly events include activities for all ages, games, music and food.
“We're here to provide hope and support for the 1.4 million Americans affected by Crohn's and colitis,” Rick Geswell, president & CEO of the CCFA, said in the press release. “We are grateful for everyone who helps raise awareness and crucial funds through programs like Take Steps, and I assure you that all money raised is used wisely, with 82 cents of every dollar spent going toward groundbreaking research, patient and professional education, and patient support programs.”